XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Cash Proceeds and Aggregate Fair Value of Stock Options Exercised In addition, there were no stock options exercised during the years ended December 31, 2023, 2022 and 2021.
Schedule of Stock Options Activity
The following table sets forth a summary of the stock option activity, weighted-average exercise prices and options outstanding as of December 31, 2023, 2022 and 2021 as follows (in thousands, except per share amounts and years):

 For the years ended December 31,
 202320222021
 Common
Stock
Options
Weighted
Average
Exercise
Price
Common Stock OptionsWeighted Average Exercise PriceCommon
Stock
Options
Weighted
Average
Exercise
Price
Outstanding at beginning of year:— $— $22.35 $22.35 
Granted250 $5.36 — $— — $— 
Exercised— $— — $— — $— 
Expired or forfeited— $— (5)$22.35 — $— 
Outstanding at end of year:250 $5.36 — $— $22.35 
Schedule of Vesting Activity of Restricted Stock Units A summary of the fully-vested common stock the Company issued to its non-employee directors, in connection with its non-employee director compensation, is as follows (in thousands):
 For the year ended December 31,
 202320222021
Awards issued133 70 51 
Grant date fair value of awards issued$750 $450 $525 
Schedule of Fully-vested Common Stocks Issued to Non-employee Directors
A summary of the vesting activity of restricted stock unit awards, with the respective fair value of the awards, is as follows (in thousands):
 For the year ended December 31,
 202320222021
Awards issued683 401 317 
Grand date fair value of awards issued$4,269 $2,524 $3,434 
Schedule of Non-vested Restricted Share Units
A summary of the Company's outstanding, non-vested restricted share units is as follows (in thousands, except per share amounts and years):
For the year ended December 31,
202320222021
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
Outstanding at beginning of period:1,415 $6.66 1,208 $7.96 1,076 $7.41 
Granted606 $8.30 687 $7.59 528 $10.07 
Released(683)$6.25 (401)$6.63 (317)$10.77 
Forfeited(154)$8.00 (79)$14.23 (79)$8.82 
Outstanding at end of period:1,184 $8.07 1,415 $6.66 1,208 $7.96 
Schedule of Performance Shares Units Activity
A summary of the Company's PRSU activity is presented as follows (in thousands, except per share amounts and years):
 For the year ended December 31,
202320222021
 UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
Outstanding at beginning of period:371 $9.96 388 $10.07 333 $8.84 
Granted282 $8.50 341 $6.55 189 $12.59 
Performance condition adjustments, net(305)$8.34 (285)$7.71 (56)$9.27 
Released(204)$6.59 (73)$5.17 (78)$8.15 
Forfeited(84)$6.95 — $— — $— 
Outstanding at end of period:60 $9.33 371 $9.96 388 $10.07